Evaluation of the BRAINDEX Brain Monitor in Cardiac Surgery, Interventional Comparative Study
ARGOS Platform
1 other identifier
interventional
40
1 country
1
Brief Summary
The main objective of this study is to show the concordance of the SctO2 values of the ARGOS platform with the standard SctO2 values (comparative study with platform INVOS, Medtronic).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2024
CompletedFirst Submitted
Initial submission to the registry
September 10, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2025
CompletedMay 16, 2025
March 1, 2025
Same day
September 10, 2024
May 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of SctO2 values from ARGOS and INVOS
Compare ARGOS and INVOS SctO2 values at different times of interest during the procedure. Compare ARGOS SctO2 values with invasive central venous and arterial saturation (measured by gasometry) during aortic unclamping. Compare INVOS SctO2 values with central venous and arterial saturation before, during and after aortic unclamping.
During the surgical procedure
Secondary Outcomes (1)
ANI and Database
During the surgical procedure
Study Arms (1)
One center and 40 patients
EXPERIMENTALMonitor the values of 3 brain parameters: SctO2, bcSEF and ANI measured by the ARGOS sensor.
Interventions
The study procedure consists of monitoring the values of 3 cerebral parameters: SctO2, bcSEF and ANI measured by the ARGOS sensor. These 3 parameters will be recorded and compared after the intervention with 3 parameters considered as standard: SctO2 measured by the INVOS 7100 cerebral oximeter, the bispectral index (BIS) measured by the BIS monitor and the ANI measured by the MDoloris monitor. These 3 reference parameters are once again usually monitored and recommended for all cardiac surgery.
Eligibility Criteria
You may qualify if:
- Patient, male or female, over 18 years of age
- Patient scheduled for cardiac surgery with programmed extracorporeal circulation (ECC)
- Patient with no history of scalp injury or or skin diseases
- Patient with an Euroscore 2 of less than 7%.
- Patient affiliated or entitled to a social assurance
You may not qualify if:
- Weight under 40 kg
- Frontal surface too small to allow application of SctO2, BIS electrodes on the same hemifront
- Patient with severe, unbalanced hypertension
- Measurement of systolic blood pressure (SBP) \> 180 mm Hg and/or diastolic blood pressure (DBP) \> 110 mm Hg
- Patients undergoing emergency surgery
- Patient with chronic renal failure, with glomerular filtration \< 30 ml/min/1.73m², or requiring renal transplantation or requiring renal transplantation
- Patient with left ventricular ejection fraction \< 40%
- Patient with a history of ischemic stroke
- Patients with preoperative sepsis
- Patient requiring noradrenaline infusion noradrenaline infusion in the 24 hours prior to surgery
- Patient with preoperative uni or bilateral carotid stenosis bilateral carotid stenosis \> 50%.
- Protected patient: adult under guardianship, curatorship or legal protection, deprived of liberty by judicial or administrative decision.
- Pregnant, parturient or breast-feeding women.
- Patients hospitalized without consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Braindexlead
- Clinique de la Sauvegardecollaborator
Study Sites (1)
Clinique de la Sauvegarde
Lyon, 69009, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2024
First Posted
September 19, 2024
Study Start
September 9, 2024
Primary Completion
September 9, 2024
Study Completion
March 3, 2025
Last Updated
May 16, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share